Clinical Trial

Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 Diabetes

Name: Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 Diabetes — clinical trial record (NCT07039981)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

The purpose of the study is to assess the safety and efficacy of a next generation automated insulin delivery algorithm in adults with type 2 diabetes aged 16-70 years old

Protocol Amendment History 1 change

critical Trial completed 2026-06-02

Trial Details

NCT Number	NCT07039981
Lead Sponsor	Insulet Corporation
Conditions	Diabetes Mellitus
Enrollment	48 participants
Start Date	2025-07-01
Primary Completion	2026-05-06 (estimated)
Study Completion	2026-05-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-01